SCHEMBL29427244

SCHEMBL29427244

CNc1ncc2cc(-c3cc(N)c(F)cc3C)c(C)nc2n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ BRAF P15056 8/20 0.56
▸ RAF1 P04049 8/20 0.56
▸ KDR P35968 6/20 0.56
▸ KRAS P01116 5/20 0.56
▸ ARAF P10398 2/20 0.56
▸ ABL1 P00519 2/20 0.56
▸ EPHA2 P29317 2/20 0.56
▸ MAPK8 P45983 2/20 0.56
▸ EPHB4 P54760 2/20 0.56
▸ MAPK13 O15264 1/20 0.56
▸ FYN P06241 1/20 0.56
▸ SRC P12931 1/20 0.56
▸ CSK P41240 1/20 0.56
▸ MAPK9 P45984 1/20 0.56
▸ IRAK1 P51617 1/20 0.56
▸ MAPK12 P53778 1/20 0.56
▸ MAPK10 P53779 1/20 0.56
▸ MAP2K5 Q13163 1/20 0.56
▸ MAP3K1 Q13233 1/20 0.56
▸ MAPK11 Q15759 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15269552 1.00 BRAF (0.56) BRAFRAF1KDRKRASARAF
SCHEMBL24457860 0.90 BRAF (0.51) BRAFRAF1KDRKRASARAF
SCHEMBL16667723 0.82 KDR (0.55) BRAFRAF1KDRKRASARAF
SCHEMBL15269452 0.82 KDR (0.45) BRAFRAF1KDRKRASARAF
SCHEMBL24457859 0.81 RAF1 (0.56) BRAFRAF1KDRKRASARAF
SCHEMBL24457872 0.81 BRAF (0.48) BRAFRAF1KDRKRASARAF
SCHEMBL22625545 0.80 BRAF (0.61) BRAFRAF1KDRKRASARAF
SCHEMBL15269365 0.80 BRAF (0.72) BRAFRAF1KDRKRASARAF
SCHEMBL24457875 0.80 BRAF (0.48) BRAFRAF1KDRKRASARAF
SCHEMBL15269745 0.80 BRAF (0.42) BRAFRAF1KDRKRASARAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023283369-A1 MODULATORS OF PROTEIN KINASES VIBLIOME THERAPEUTICS, LLC (US) 2023-01-12 — — WO disclosed
EP-3962484-A1 INHIBITORS OF RAF KINASES Kinnate Biopharma Inc. (US) 2022-03-09 — — EP disclosed
Send feedback